ATLASATLAS fair value
SEK 163.45
Close to fair value · 5% premium
Range: SEK 114–SEK 226Fair valuePrice
CellaVision (CEVI.ST)
CellaVision stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Nasdaq Stockholm · Sweden
SEK 171.00▲ +0.71%
Prices as of Oct 26, 2026 · SEK
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on CellaVision in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On CellaVision
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates CellaVision's fair value at about SEK 163.45 per share (reasonable range: SEK 114.09 to SEK 226.06). At SEK 171.00, the stock trades within 8% of that figure: close to fair value.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives CellaVision a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 162.58 and SEK 180.56; in 9 out of 10, between SEK 148.15 and SEK 198.15. Estimated annual volatility is 24%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 3.9B
- Market cap (USD)
- $394M
- P/E ratio
- 30.5
- Dividend yield
- 1.68%
- 52-week high
- SEK 191.20
- 52-week low
- SEK 117.60
- Revenue (12 months)
- SEK 739M
- Gross margin
- 68.7%
- Operating margin
- 20.6%
- Net margin
- 17.5%
- Beta
- 0.92
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. CellaVision sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks CEVI.ST has traded between SEK 117.60 and SEK 191.20. Today it is 10.6% below that high and 45% above its low.
On the business: net margin is 17.5%; it trades at 30.5 times earnings.
Its beta is 0.92: it moves roughly in line with the market.
About the company
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally.
Want to see everything about CellaVision?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is CellaVision (CEVI.ST) fair value?
About SEK 163.45 per share according to ATLAS (reasonable range: SEK 114.09 to SEK 226.06). With the stock at SEK 171.00, it is close to that value.
What is the chance CEVI.ST goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, CEVI.ST ends the month between SEK 162.58 and SEK 180.56.
How big is CellaVision and what is its P/E ratio?
CellaVision's market capitalization is SEK 3.9B. Its price-to-earnings (P/E) ratio is 30.5: you pay SEK 30.5 for each SEK 1.00 of yearly earnings.
Does CellaVision pay a dividend?
Yes. CEVI.ST's current dividend yield is 1.68% at today's price (SEK 171.00).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer